Avaliação do efeito ANTI-Toxoplasma gondii de compostos metalocomplexos N0414 e N5814 não coordenados a sulfadiazina

Detalhes bibliográficos
Ano de defesa: 2017
Autor(a) principal: Duarte, Ary Guedes Porto
Orientador(a): Seabra, Sérgio Henrique, Fortes, Fabio da Silva Azevedo
Banca de defesa: Seabra, Sergio Henrique, Redner, Paulo, Barbosa, Júlio Vianna, Sant’Anna Filho, Celso Barbosa de, Santos, Eidy
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade do Grande Rio
Programa de Pós-Graduação: Programa de Pós-Graduação em Ensino das Ciências
Departamento: Unigranrio::Ensino das Ciências
País: Brasil
Palavras-chave em Português:
Área do conhecimento CNPq:
Link de acesso: http://localhost:8080/tede/handle/tede/368
Resumo: Toxoplasma gondii, toxoplasmosis agent, is a obligate intracellular protozoan that is able of infecting a broad spectrum of vertebrate’s cells. Toxoplasmosis is a pathology related to severe damages to immunocompromised hosts and its current chemotherapy is quite restricted, being more used the combination of sulfadiazine and pyrimethamine, which is a therapy associated with adverse reactions. This fact highlights the importance of the study of new drugs against Toxoplasma gondii. Has been studied the biological effect of new metallocomplexe compounds, which are inorganic compounds that present promising biological activity as fungicide, bactericide and antiviral. The metallocomplexes, dinuclear ferric compounds N0414 (Fe alfanaftol BMPA) and N5814 (Fe beta-naphthol BMPA) showed activity against Toxoplasma gondii in vitro and it was nontoxic to LLC-MK2 cells, being able to reduce the activity of crucial antioxidant enzymes for the defense of the parasite. In this project, it will be investigated the activities of compounds of the metallocomplexes family as the compounds coordinated to sulfadiazine as the nucleus compound of ferric N0414 and N5814, which showed anti-Toxoplasma gondii activities and were able to eliminate the infection in almost all host cells. In further steps, we will investigate what kind of death the parasite undergoes after the treatment with the compounds through the ultrastructure analysis and the usage of specific markers by fluorescence microscopy. Due to the promising results found in this work, to prove their efficacy the compounds will also be used in in vivo tests with murine models under the acute phase of toxoplasmosis.